Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novartis AG Common Stock (NY:NVS)

153.66 -0.21 (-0.14%)

Streaming Delayed Price Updated: 12:21 PM EDT, Jul 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	742,455
Open	156.07
Bid (Size)	153.64 (100)
Ask (Size)	153.68 (100)
Prev. Close	153.87
Today's Range	153.54 - 156.41
52wk Range	112.34 - 170.46
Shares Outstanding	N/A
Dividend Yield	3.11%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Novartis (NVS) Q2 2026 Earnings Call Transcript ↗

July 21, 2026

Growth drivers offset generic erosion as priority brands surge 36% in constant currency.

Via The Motley Fool

Novartis Q2 Earnings Call Highlights ↗

July 21, 2026

Novartis (NYSE:NVS) said it returned to sales growth in the second quarter of 2026, supported by strong gains across priority medicines and launches, while reaffirming its full-year outlook despite...

Via MarketBeat

Performance

YTD	+10.9%	+10.9%
1 Month	+3.2%	+3.2%
3 Month	+3.8%	+3.8%
6 Month	+7.0%	+7.0%
1 Year	+34.6%	+34.6%

More News

Novartis Q2 2026 Earnings Call Transcript ↗

July 21, 2026

Via Benzinga

Novartis Bounds For Buy Point. Why Shares Are On The Rise. ↗

July 21, 2026

Via Investor's Business Daily

NOVARTIS AG-SPONSORED ADR (NYSE:NVS): High-Quality Dividend Stock With Strong Profitability and Sustainable Payout ↗

July 07, 2026

Via Chartmill

Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline ↗

July 21, 2026

Via Benzinga

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026? ↗

July 20, 2026

Via The Motley Fool

This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval ↗

July 17, 2026

Via Benzinga

StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data

July 14, 2026

Via Newsfile

Global Nitrogen-Containing Bisphosphonate Drugs Market Growing at 3.1% CAGR Through 2032 ↗

July 14, 2026

Via Talk Markets

Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? ↗

July 09, 2026

Via The Motley Fool

What Is the Vanguard International Dividend Appreciation ETF (VIGI), and Who Should Buy It? ↗

July 09, 2026

Via The Motley Fool

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up? ↗

July 09, 2026

Via The Motley Fool

VYMI vs. VIGI: Which International Dividend ETF Is Better? ↗

July 09, 2026

Via The Motley Fool

2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗

July 08, 2026

Via The Motley Fool

The Market Just Got Shaken—These 3 ETFs May Come Out Stronger ↗

July 08, 2026

Via MarketBeat

MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition

July 06, 2026

Via Investor Brand Network

Novartis Scoops up UK Biotech Myricx in $1.5 Billion Cancer Push ↗

July 06, 2026

Via Benzinga

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP? ↗

July 04, 2026

Via The Motley Fool

New Research Says: The Biggest Gains of AI Won't Go to AI Stocks. These 2 ETFs Could Be Better Buys. ↗

July 04, 2026

Via The Motley Fool

IEFA vs. VXUS: Both Are Cheap. Both Are Broad. Here Is the Key Difference Long-Term Investors Need to Understand. ↗

July 02, 2026

Via The Motley Fool

3 European Stocks to Carry Investors Through the Back Half of 2026 ↗

July 01, 2026

Via MarketBeat

Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston

June 29, 2026

Via Press Release Distribution Service

Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗

June 29, 2026

Via The Motley Fool

Novartis, Antares Partner To Pursue Undruggable Cancer Targets In $1.9 Billion Deal ↗

June 24, 2026

Via Benzinga

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?

Yes, Novartis AG Common Stock is publicly traded.

What exchange does Novartis AG Common Stock trade on?

Novartis AG Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Novartis AG Common Stock?

The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange

What is the current price of Novartis AG Common Stock?

The current price of Novartis AG Common Stock is 153.66

When was Novartis AG Common Stock last traded?

The last trade of Novartis AG Common Stock was at 07/22/26 12:21 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.